From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection technology is fueling breakthroughs made possible through its unparalleled sensitivity and flexibility. Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum, or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Our industry-leading precision instruments, digital immunoassay technology, and CLIA-certified Accelerator laboratory support research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease.
Our Simoa® Bead Technology allows researchers to measure biomarkers at femtogram levels with simple and scalable workflows.
How it works:
Quanterix offers two instruments that utilize bead technology. The HD-X™ Automated Immunoassay Analyzer offers a fully automated Simoa® bead-based immunoassay platform designed to multiplex up to 4 biomarkers in a single assay with unrivaled sensitivity. The SR-X™ Biomarker Detection System is our semi-automated benchtop instrument for running bead-based assays.
Choose The Right Platform For Your Research.
Utilize our CLIA-certified laboratory as a cost-effective, outsourced solution for your custom biomarker and biopharmaceutical research, assay development, and clinical sample testing needs.
The HD-XTM Automated Immunoassay Analyzer is the latest model of the fully automated Simoa bead-based immunoassay platform. The HD-X delivers increased productivity, user flexibility, unparalleled sensitivity and best in class assay performance.
Quanterix offers the flexibility of multiplex homebrew assay development to minimize required sample volume; providing full kits that include all reagents and training required to develop these custom homebrew assays.